Effect of Mindfulness on Pain After Total Knee Arthroplasty
Launched by ROTHMAN INSTITUTE ORTHOPAEDICS · Oct 31, 2023
Trial Information
Current as of July 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing unilateral primary TKA
- • AND
- • Patients with MDD who take medication for MDD and/or Patients with GAD who take medication for GAD
- • Patients with MDD and/or Patients with GAD who are being treated for those conditions with psychotherapy by a psychologist or psychiatrist
- • Patients with an SF-12 Mental Health Score less than 45.6
- • Owning a smartphone (Apple or Android) to be able to download the mindfulness application
- Exclusion Criteria:
- • Patients undergoing bilateral TKA
- • Patients undergoing revision TKA
- • Patients with mental health conditions other than MDD and/or GAD
- • Patients currently utilizing a mindfulness application
About Rothman Institute Orthopaedics
Rothman Institute Orthopaedics is a leading healthcare organization specializing in orthopedic care and research. With a commitment to advancing the field of orthopedics, Rothman Institute conducts innovative clinical trials aimed at improving patient outcomes and enhancing treatment methodologies. Renowned for its team of highly skilled orthopedic surgeons and researchers, the institute integrates cutting-edge technology and evidence-based practices to deliver exceptional care. Through its rigorous research initiatives, Rothman Institute is dedicated to fostering advancements in orthopedic medicine and contributing to the overall improvement of musculoskeletal health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported